| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/26/2009 | US20090054506 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 02/26/2009 | US20090054505 such as 5-(3-((R)-3-(4-((S)-1-hydroxyhexyl)phenyl)-4-oxooxazolidin-2-yl)propyl)thiophene-2-carboxylic acid, used for the reduction of intraocular pressure and treament of glaucoma |
| 02/26/2009 | US20090054504 Modified Release Formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and Methods of Using the Same |
| 02/26/2009 | US20090054503 Composition |
| 02/26/2009 | US20090054502 Benzimidazole Derivative and Use as Angiotensin II Antagonist |
| 02/26/2009 | US20090054501 Azole compounds used as tuberculostatic and leishmanicide agents |
| 02/26/2009 | US20090054500 Composition and methods useful in preventing cardiac hypertrophy |
| 02/26/2009 | US20090054499 results in little or no liver damage |
| 02/26/2009 | US20090054498 Anhydrous Compositions Useful for Attaining Enhanced Sexual Wellness |
| 02/26/2009 | US20090054497 Methods for attaining enhanced sexual wellness using anhydrous compositions |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054494 Peroxisome proliferator-activated receptor agonists; insulin resistance; neurodegenerative disorders ; N-{2-[4-(5-Isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-phenyl]-ethyl}-2-methoxy-4-trifluoromethyl-benzamide |
| 02/26/2009 | US20090054493 Thiazole derivatives as ppar delta ligands and their manufacturing process |
| 02/26/2009 | US20090054491 Use |
| 02/26/2009 | US20090054490 Methods for the treatment of gerd with mglur5 antagonists |
| 02/26/2009 | US20090054489 Multimediator Dopamine Transport Inhibitors, and Uses Related Thereto |
| 02/26/2009 | US20090054488 Isomigrastatin Analogs In The Treatment Of Cancer |
| 02/26/2009 | US20090054487 Pharmaceutical composition for increasing the mitochondrial genesis |
| 02/26/2009 | US20090054486 Polymorphic form xvi of fexofenadine hydrochloride |
| 02/26/2009 | US20090054485 Method of treating neutrophil-related diseases with topical anesthetics |
| 02/26/2009 | US20090054484 Substituted heteroaryl benzofuran acids |
| 02/26/2009 | US20090054483 Substituted Quinolines as Inhibitors of Leukotriene Biosynthesis |
| 02/26/2009 | US20090054482 Method of making and administering quinoline derivatives as anti-cancer agents |
| 02/26/2009 | US20090054481 Saquinavir Mesylate Oral Dosage Form |
| 02/26/2009 | US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same |
| 02/26/2009 | US20090054479 Fused heterocyclic derivatives as ppar modulators |
| 02/26/2009 | US20090054478 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| 02/26/2009 | US20090054477 4-thio substituted quinoline and naphthyridine compounds |
| 02/26/2009 | US20090054476 A3 Adenosine receptor allosteric modulators |
| 02/26/2009 | US20090054475 treatment of Type II diabetes and other diseases associated with poor glycemic control |
| 02/26/2009 | US20090054474 2-[N-[3-(N-cyclopentylmethyl-N-ethyl)amino-6-methoxypyridin-2-yl]methyl-N-(3-trifluoromethylbenzyl)]amino-5-(2-methylthioethoxy)pyrimidine, having cholesterol ester transfer protein inhibitory activity, used for treating hyperlipidemia and arteriosclerotic diseases |
| 02/26/2009 | US20090054473 Therapy for complications of diabetes |
| 02/26/2009 | US20090054472 Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof |
| 02/26/2009 | US20090054471 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs |
| 02/26/2009 | US20090054469 Quinazolinone derivatives and their use as b-raf inhibitors |
| 02/26/2009 | US20090054468 New Use 938 |
| 02/26/2009 | US20090054467 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases |
| 02/26/2009 | US20090054466 Leukotriene B4 Inhibitors |
| 02/26/2009 | US20090054465 N-hydroxyacrylamide compounds |
| 02/26/2009 | US20090054464 Hdac inhibitor |
| 02/26/2009 | US20090054463 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 02/26/2009 | US20090054462 Hydroisoindoline tachykinin receptor antagonists |
| 02/26/2009 | US20090054461 Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder |
| 02/26/2009 | US20090054460 Piperazine derivatives and methods of use |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054458 Use of a polymorph of flibanserin for treating disease |
| 02/26/2009 | US20090054457 Substituted heterocyclic compounds |
| 02/26/2009 | US20090054456 Benzylpiperazine derivatives and their medical use |
| 02/26/2009 | US20090054455 Aripiprazole co-crystals |
| 02/26/2009 | US20090054454 Benzofuranyl- and benzothienyl- piperazinyl quinolines and methods of their use |
| 02/26/2009 | US20090054453 Novel Tetralins as 5-HT6 Modulators |
| 02/26/2009 | US20090054452 Thienopyridine Derivatives and the Use Thereof as Hsp90 Modulators |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054450 Compositions and methods of use for treating or preventing lipid related disorders |
| 02/26/2009 | US20090054449 Substituted N-heterocyclic Compounds and Their Use as Dopamine D3 Receptor Ligands |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054447 2,3 Substituted Pyrazine Sulfonamides as Inhibitors of CRTH2 |
| 02/26/2009 | US20090054446 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 02/26/2009 | US20090054445 Amide Substituted Quinolines |
| 02/26/2009 | US20090054444 2(R)-2-(4-cyclopropanesulfonylphenyl)-N-(1-methylpyrazol-3-yl)-3-((R)-3-oxocyclopentyl)propionamide, useful in the prophylaxis and treatment of hyperglycemia and diabetes; hypoglycemic and antidiabetic agents |
| 02/26/2009 | US20090054443 Compositions containing riboflavin and sesamin-class compounds |
| 02/26/2009 | US20090054442 Method of administering ophthalmic fluids |
| 02/26/2009 | US20090054441 Process For The Preparation of an Optically Active 5H-Pyrrolo [3,4-B] Pyrazine Derivative |
| 02/26/2009 | US20090054440 Quinoline derivatives as neurokinin receptor antagonists |
| 02/26/2009 | US20090054439 Sulfonamide derivatives, preparation and therapeutic application thereof |
| 02/26/2009 | US20090054438 Compositions and methods for inhibiting growth and metastasis of melanoma |
| 02/26/2009 | US20090054437 Nitrocatechol Derivatives as Comt Inhibitors |
| 02/26/2009 | US20090054436 anticarcinogenic compounds; ; N-(4-(2-Aminopyridin-4-yloxy)-3-fluorophenyl)-2-bromoisonicotinamide, trifluoroacetic acid salt; inhibit the protein tyrosine kinase activity of growth factor receptors like Hepatocyte growth factor |
| 02/26/2009 | US20090054435 Phenoxyalkanoic Acid Compound |
| 02/26/2009 | US20090054434 Isoquinolone derivatives as phosphodiesterase 10 inhibitors |
| 02/26/2009 | US20090054433 Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist |
| 02/26/2009 | US20090054432 2-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA Inhibitors |
| 02/26/2009 | US20090054431 Novel heterocycle compounds |
| 02/26/2009 | US20090054430 Inhibitors of Protein Kinases |
| 02/26/2009 | US20090054429 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 02/26/2009 | US20090054428 Novel pyrimidine derivatives 965 |
| 02/26/2009 | US20090054427 Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors |
| 02/26/2009 | US20090054426 Treatment of central nervous system disorders |
| 02/26/2009 | US20090054425 Protein kinase inhibitors |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054423 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 02/26/2009 | US20090054422 New Oxabispidine Compounds For The Treatment Of Cardiac Arrhythmias |
| 02/26/2009 | US20090054421 Pyrimidothiophene Compounds Having HSP90 Inhibitory Activity |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054419 3,7-diamino-10h-phenothiazine salts and their use |
| 02/26/2009 | US20090054418 8-(2-{cis-4-[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-hydroxycyclohexyl}ethyl)-2H-chromen-2-one; may be formulated for administration in any convenient way; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 02/26/2009 | US20090054417 Compounds and compositions as modulators of steroid hormone nuclear receptors |
| 02/26/2009 | US20090054416 1,4-Diazabicyclo[3.2.2]nonanecarboxamide Derivatives, Preparation and Therapeutic Use Thereof |
| 02/26/2009 | US20090054415 Combinations, methods and compositions for treating cancer |
| 02/26/2009 | US20090054414 treating kindling and improving resilience |
| 02/26/2009 | US20090054413 Novel 5,6-Dihydropyrazolo[3,4-E] [L,4]Diazepin-4 (IH) -One Derivatives for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease |
| 02/26/2009 | US20090054412 Treatment of Sleep Disorders |
| 02/26/2009 | US20090054411 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors |
| 02/26/2009 | US20090054410 Thiadiazole derivatives for the treatment of neurodegenerative diseases |
| 02/26/2009 | US20090054409 [4-(4-imidazo[1,2-a]pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-morpholin-4-yl-methanone, used for treating rheumatoid arthritis in mammals |
| 02/26/2009 | US20090054408 2-(2-Oxo-3-pyridin-2-ylimidazolidin-1-yl)-N-(2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide; CGRP (Calcitonin Gene-Related Peptide); headache, migraine or cluster headache |
| 02/26/2009 | US20090054407 such as 4-Methanesulfonyloxy-5-methoxy-7-[1H-5-(methylaminomethyl)indol-2-yl]isoindolinone, having an antitumor activity |
| 02/26/2009 | US20090054406 Compositions and Methods for Modulating Endophthalmitis Using Fluoroquinolones |
| 02/26/2009 | US20090054405 PI3 kinase modulators and methods of use |
| 02/26/2009 | US20090054404 Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain |